AllantoinvsVitamin E (Tocopherol)

Allantoin (5-ureidohydantoin) stimulates cell proliferation and tissue regeneration by promoting fibroblast activity, keratinocyte proliferation, and extracellular matrix synthesis including collagen and glycosaminoglycans. It acts as a mild keratolytic by promoting the natural desquamation process—loosening corneocyte adhesion and facilitating shedding—without the irritation, pH disruption, or barrier compromise associated with alpha- or beta-hydroxy acids. Allantoin has anti-inflammatory properties through modulation of prostaglandin synthesis (inhibiting COX-2 and reducing PGE2) and may downregulate pro-inflammatory cytokines. Its moisturizing effect comes from increasing the water-binding capacity of the extracellular matrix and stratum corneum; it is highly soluble and forms hydrogen bonds with water. Allantoin also promotes wound epithelialization. Its safety profile—non-irritating, non-sensitizing, non-comedogenic—makes it suitable for compromised skin, post-procedure care, and infant formulations.

Vitamin E (alpha-tocopherol) is the skin's primary lipid-soluble antioxidant, concentrated in stratum corneum and sebum. Donates hydrogen from chromanol ring to neutralize lipid peroxyl radicals (LOO•), preventing peroxidation chain reaction in cell membranes. After donating, becomes tocopheroxyl radical, regenerated by vitamin C via ascorbate-tocopherol cycle — why C+E+ferulic is synergistic. Modulates UV-induced inflammation: inhibits protein kinase C, NF-kappa B activation, reduces PGE2 synthesis. Inhibits 5-lipoxygenase, decreasing leukotriene production. Accumulates in sebaceous glands, delivered via sebum as first-line antioxidant defense. Protects polyunsaturated fatty acids from oxidative damage.